Literature DB >> 7636027

Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

K E Bowenkamp1, A F Hoffman, G A Gerhardt, M A Henry, P T Biddle, B J Hoffer, A C Granholm.   

Abstract

Glial cell-lined derived neurotrophic factor (GDNF) has been shown to promote survival of developing mesencephalic dopaminergic neurons in vitro. In order to determine if there is a positive effect of GDNF on injured adult midbrain dopaminergic neurons in situ, we have carried out experiments in which a single dose of GDNF was injected into the substantia nigra following a unilateral lesion of the nigrostriatal system. Rats were unilaterally lesioned by a single stereotaxic injection of 6-hydroxydopamine (6-OHDA; 9 micrograms/4 microliters normal saline with 0.02% ascorbate) into the medial forebrain bundle and tested weekly for apomorphine-induced (0.05 mg/kg s.c.) contralateral rotation behavior. Rats that manifested > 300 turns/hour received a nigral injection of 100 micrograms GDNF, or cytochrome C as a control, 4 weeks following the 6-OHDA lesion. Rotation behavior was quantified weekly for 5 weeks after GDNF. Rats were subsequently anesthetized, transcardially perfused, and processed for tyrosine hydroxylase immunohistochemistry. It was found that 100 micrograms GDNF decreased apomorphine-induced rotational behavior by more than 85%. Immunohistochemical studies revealed that tyrosine hydroxylase immunoreactivity was equally reduced in the striatum ipsilateral to the lesion in both cytochrome C and GDNF-injected animals. In contrast, large increments in tyrosine hydroxylase immunoreactivity were observed in the substantia nigra of animals treated with 100 micrograms of GDNF, with a significant increase in numbers of tyrosine hydroxylase-immunoreactive cell bodies and neurites as well as a small increase in the cell body area of these neurons. The results suggest that GDNF can maintain the dopaminergic neuronal phenotype in a number of nigral neurons following a unilateral nigrostriatal lesion in the rat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636027     DOI: 10.1002/cne.903550402

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  46 in total

1.  GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis.

Authors:  C M Kearns; W A Cass; K Smoot; R Kryscio; D M Gash
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 2.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

3.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

4.  Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.

Authors:  Stefan Jean-Pierre Haas; Stanislav Petrov; Golo Kronenberg; Oliver Schmitt; Andreas Wree
Journal:  J Anat       Date:  2007-11-23       Impact factor: 2.610

5.  Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat.

Authors:  Tinmarla Frances Oo; Vincent Ries; Jinwhan Cho; Nikolai Kholodilov; Robert E Burke
Journal:  J Comp Neurol       Date:  2005-03-28       Impact factor: 3.215

6.  Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.

Authors:  S Hunot; V Bernard; B Faucheux; F Boissière; E Leguern; C Brana; P P Gautris; J Guérin; B Bloch; Y Agid; E C Hirsch
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.

Authors:  A C Granholm; M Reyland; D Albeck; L Sanders; G Gerhardt; G Hoernig; L Shen; H Westphal; B Hoffer
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 8.  Neurotrophic factors for the investigation and treatment of movement disorders.

Authors:  Justo Garcia De Yébenes; Marina Sánchez; Maria Angeles Mena
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene.

Authors:  Heather A Boger; Lawrence D Middaugh; Vandana Zaman; Barry Hoffer; Ann-Charlotte Granholm
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

10.  Aged Tgfbeta2/Gdnf double-heterozygous mice show no morphological and functional alterations in the nigrostriatal system.

Authors:  Stephan Heermann; Felipe Opazo; Björn Falkenburger; Kerstin Krieglstein; Björn Spittau
Journal:  J Neural Transm (Vienna)       Date:  2010-05-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.